Lack of glycemic control in type two diabetes mellitus patients is associated with reduced serum epidermal growth factor level and increased insulin resistance
Authors:
Open Access
- 29 October 2024
- journal article
- research article
- Published by Spandidos Publications in Biomedical Reports
- Vol. 22 (1) , 1-11
Abstract
The prevalence of type 2 diabetes mellitus (T2DM) is steadily increasing worldwide in an alarming fashion. Importantly, poor glycemic control is associated with development of various health sequalae's due to glucolipotoxicity, oxidative stress and increased inflammatory cytokines. The aim of the present study was to examine the effect of glycemic control on the relative abundance of inflammatory markers in patients with controlled and uncontrolled T2DM, and to test their association with the glycemic status in diabetic patients in Jordan. An observational cross‑sectional study design was used. Patients with T2DM with controlled diabetes [glycated hemoglobin (HbA1c) ≤7.0%, n=110] and age‑, sex‑ and body mass index (BMI)‑matched uncontrolled diabetic patients (HbA1c >7.0%, n=105) were recruited. An antibody membrane array was used to examine the relative abundance of inflammatory cytokines and growth factors in the sera of the study subjects, followed by enzyme‑linked immunosorbent assay (ELISA) to confirm the results. Fasting blood glucose, serum insulin, triglyceride and homeostatic model assessment for insulin resistance (HOMA‑IR) score were significantly elevated in the uncontrolled T2DM group (P1c (r=‑0.25, P1c, (r=0.32, P1c indicative of diabetic control.Keywords
This publication has 46 references indexed in Scilit:
- EGF regulates survivin stability through the Raf-1/ERK pathway in insulin-secreting pancreatic β-cellsBMC Molecular Biology, 2010
- Epidermal growth factor increases insulin secretion and lowers blood glucose in diabetic miceJournal of Cellular and Molecular Medicine, 2008
- Loss of Glycemic Control in Patients with Type 2 Diabetes Mellitus Who Were Receiving Initial Metformin, Sulfonylurea, or Thiazolidinedione MonotherapyPharmacotherapy: The Journal of Human Pharmacology and Drug Therapy, 2007
- Does Epidermal Growth Factor Participate in the Regulation of Glucose, Insulin and Glucagon Levels?European Surgical Research, 2006
- Glycemic Control Continues to Deteriorate After Sulfonylureas Are Added to Metformin Among Patients With Type 2 DiabetesDiabetes Care, 2005
- In vitro generation of insulin-producing beta cells from adult exocrine pancreatic cellsDiabetologia, 2004
- The role of epidermal growth factor and its receptors in mammalian CNSCytokine & Growth Factor Reviews, 2004
- Epidermal Growth Factor Protects against Pancreatic Damage in Cerulein-Induced PancreatitisDigestion, 1999
- Excretion of urinary epidermal growth factor in non-insulin dependent diabetes mellitusLife Sciences, 1993
- Epidermal growth factor deficiency associated with diabetes mellitus.Proceedings of the National Academy of Sciences, 1989